相似文献
1
Immunological changes and practolol.
Lancet. 1976 Dec 11;2(7998):1298. doi: 10.1016/s0140-6736(76)92055-9.
2
Adverse reaction to the beta-adrenergic blocking drugs.
Br J Dermatol. 1976 Sep;95(3):335-8. doi: 10.1111/j.1365-2133.1976.tb07026.x.
3
Problems with practolol.
Drugs. 1975;10(5-6):336-41. doi: 10.2165/00003495-197510050-00003.
4
Possible role of antibody specific for a practolol metabolite in the pathogenesis of oculomucocutaneous syndrome.
Br Med J. 1978 Feb 18;1(6110):402-4. doi: 10.1136/bmj.1.6110.402.
5
Editorial: side effects of practolol.
Br Med J. 1975 Jun 14;2(5971):577-8.
6
Immunological abnormalities in patients who had the oculomucocutaneous syndrome associated with practolol therapy.
Lancet. 1976 Nov 6;2(7993):984-7. doi: 10.1016/s0140-6736(76)90831-x.
7
Practolol-induced autoantibodies and their relation to oculo-cutaneous complications.
Postgrad Med J. 1977 Feb;53(616):75-7. doi: 10.1136/pgmj.53.616.75.
8
[Adverse effects of practolol].
Duodecim. 1976;92(22):1264-5.
9
Adverse effects of practolol.
Ann Clin Res. 1976 Aug;8(4):229-31.
10
Letter: Practolol.
Med J Aust. 1975 May 24;1(21):664.
Zotero 插件